Agilent Technologies (A) Osake Kurssi
Agilent Technologies Kurssi
Viimeisten 19 vuoden aikana Agilent Technologiesn liikevaihto kasvoi 1,8 % vuodessa ja ylsi 6,95 Mrd. USD:een. Osakekohtainen tulos on laskenut 2,8 % vuodessa viimeisten 19 vuoden aikana. Agilent Technologiesn nettomarginaali 18,8 % on pääosin vakaa verrattuna 19,1 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 0,42 %. Jakosuhde on noin 16 % tuloksesta. Osinko on kasvanut 4,9 % vuodessa viimeisten 13 vuoden aikana. Agilent Technologiesn 12 kuukauden konsensustavoitehinta on 152,50 USD, noin ali kurssia 13,1 %. 30 analyytikosta 22 suosittaa ostoa — kokonaiskonsensus on Osta.
Agilent Technologies osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Agilent Technologies liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Agilent Technologies -osakkeesta
Agilent Technologies Inc. operates with a business model focused on life sciences, diagnostics, and applied chemical markets. As a global leader in bio-analytical measurement solutions, Agilent provides a wide range of instruments, software, consumables, services, and solutions. The company offers solutions that enable customers in various industries to explore and understand the biological world, improve healthcare diagnostics, and develop new scientific applications. With its strong expertise in measurement and analysis, Agilent aims to empower scientists and researchers with innovative technologies to address critical challenges in areas like medical research, pharmaceutical development, environmental testing, and more.
Agilent Technologies Inc is primarily active in the industries of healthcare, diagnostics, and life sciences.
Some of the main competitors of Agilent Technologies Inc in the market are Thermo Fisher Scientific Inc, Waters Corporation, PerkinElmer Inc, and Shimadzu Corporation.
Agilent Technologies Inc. is a renowned company in the field of life sciences, diagnostics, and applied chemical markets. Founded in 1999, Agilent Technologies was a spin-off from Hewlett-Packard Company. It quickly established itself as a leading provider of measurement solutions, scientific instruments, and services. With a strong focus on innovation and cutting-edge technologies, Agilent Technologies has helped numerous industries advance through its products, collaborations, and expertise. Today, the company's diverse portfolio encompasses areas such as genomics, pharmaceuticals, environmental testing, and more. Agilent Technologies Inc. continues to contribute to scientific advancements and remains a trusted name in the industry.
Agilent Technologies Inc, a renowned industry leader, has achieved several significant milestones. Notably, in 1999, Agilent became an independent company after being spun-off from Hewlett-Packard. Since then, Agilent has continued to thrive and expand its market presence. Over the years, the company has gained recognition for its pioneering advancements in measurement solutions, such as the development of the world's first handheld digital multimeter and the establishment of breakthrough technologies for chemical analysis. Agilent's commitment to innovation has also secured numerous prestigious awards, including the R&D 100 Award. With a rich history of achievements, Agilent Technologies Inc remains at the forefront of cutting-edge technologies.
Agilent Technologies Inc is primarily present in various countries and regions across the globe. Some of the key locations where the company has a significant presence include the United States, Europe, China, Japan, and India. With its headquarters in Santa Clara, California, Agilent operates internationally, catering to customers in the fields of life sciences, diagnostics, and applied chemical markets. With a strong global footprint, Agilent has established a wide network of manufacturing facilities, sales offices, and research and development centers in these regions, enabling the company to serve its diverse customer base effectively.
Agilent Technologies Inc represents values of innovation, integrity, and collaboration. With a strong corporate philosophy rooted in customer success, Agilent aims to deliver reliable and high-quality solutions to enable scientific discoveries. The company strives for excellence in all aspects of their business, including environmental sustainability and social responsibility. Agilent fosters a culture of diversity and inclusion, promoting the empowerment of its employees and respecting the communities it serves. By consistently exceeding customer expectations and staying at the forefront of technology advancements, Agilent Technologies Inc demonstrates its commitment to driving progress and enabling advancements in life sciences, diagnostics, and applied chemical markets.
Analyytikot asettavat tällä hetkellä Agilent Technologies-osakkeelle keskimääräisen tavoitehinnan 153,25 USD (mediaani: 152,50 USD), mikä merkitsee −12,7 % viimeisimpään hintaan verrattuna. Konsensus perustuu 30 analyytikkoarvioon.
30 analyytikkoa arvioi tällä hetkellä Agilent Technologies-osaketta: 22 suosittaa ostoa, 8 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Agilent Technologies-yhtiöltä 7,50 Mrd. USD liikevaihtoa ja 6,22 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Agilent Technologies-osake noteerataan hintaan 156,76 EUR (175,46 USD).
Agilent Technologies-osake (A) on listattuna 9 pörssissä, muun muassa: NYSE (A), London (0HAV.L), SIX (Zürich) (AG8.SW), Frankfurt (AG8.F), München (AG8.MU), Düsseldorf (AG8.DU), Hamburg (AG8.HM).
Agilent Technologies Inc is a globally leading provider in the field of life sciences, diagnostics, and applied chemistry. The company offers a variety of products and solutions for the analysis, testing, and diagnosis of materials. The company is divided into various business segments. The Life Sciences and Applied Chemistry business segment offers products for the analysis of molecular information and biochemical interactions. These include chromatography columns, mass spectrometry systems, DNA and RNA synthesis reagents, microfluidic systems, and much more. These products are used in pharmaceutical research, biotechnology, the food industry, environmental analysis, and other fields. Another important business segment is diagnostics. Here, Agilent offers instrumental and reactive tools for cancer, genetic, and clinical diagnostics. The range includes in vitro diagnostic products, devices for clinical chemistry, as well as infection tests and diagnostic software. The high precision and sensitivity solutions are designed to improve the accuracy of clinical diagnoses and treatment outcomes and optimize patient care. Also available are systems for electronic testing and measurement technology. These include oscilloscopes, signal generators, network analyzers, and other devices for capturing and analyzing electrical signals used in the communication industry, automotive construction, and other industries. Agilent is also a significant supplier of consumables for laboratories. The range extends from solvents, sample vessels, pipettes, chemicals to clothing and training for laboratory employees. To deliver the range of offerings to customers, Agilent organizes its work according to regional markets. The company has over 50 locations worldwide, including research, production, and customer centers. The company pursues a strategy aimed at growth and expansion into new sectors and geographic regions. Agilent has deepened and expanded its expertise in new areas through acquisitions of companies in recent years, including highly specialized companies such as BioTek Instruments, ACEA Biosciences, and Lasergen, to name just a few. Agilent's business model is based on focusing on customer needs and providing high-quality products and services. The company relies on innovation and investments in research and development to solidify and expand its position in many markets. In addition, the company emphasizes the importance of environmental protection, social responsibility, fair competition, and employee satisfaction. All in all, Agilent is a significant provider of products and solutions for customers in various industries. The company is expected to remain a leader in the field of life sciences, diagnostics, and applied chemistry due to successful business development.
odotettu liikevaihto Agilent Technologies on 7,50 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Agilent Technologies on 1,77 Mrd. USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Agilent Technologies:n hinta-voitto-suhde (P/E) on tällä hetkellä 28,19. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Agilent Technologies-osakkeen arvostusta.
Agilent Technologies:n hinta-myynti-suhde (P/S) on tällä hetkellä 6,64. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Agilent Technologies-osakkeen arvostuskennuslukuna.
Agilent Technologies:n Eulpool-laatuscore on 6/10.
Agilent Technologies:n ISIN on US00846U1016. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Agilent Technologies:n WKN on 929138. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Agilent Technologies:n ticker on A. Tämä pörssinoteeraus käytetään Agilent Technologies-osakkeiden kauppaan pörssissä.
Agilent Technologies osake
Agilent Technologies vertaisryhmä
Agilent Technologies Ticker
Agilent Technologies FIGI
Kaikki tunnusluvut ja syvällinen analyysi Agilent Technologies:sta
Meidän osakeanalyysimme Agilent Technologies-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Agilent Technologies:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: